We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Pfizer Gets FDA OK for Prevnar 13 in Older Adults
Pfizer Gets FDA OK for Prevnar 13 in Older Adults
January 6, 2012
The FDA has approved an expanded indication for Pfizer’s pneumococcal pneumonia vaccine Prevnar 13, allowing its use in adults age 50 and older.